keine Finanzberatung

IDXX · IDEXX Laboratories, Inc.

Veterinary diagnostics instruments, consumables and software

Risiko 4/10 · LOW-MODERATE RISK · premium pet-health compounder · $535.38 ▲ 1.15%Von KI geschrieben

Stand der Zahlen: · Quellen: öffentliche Markt-Aggregatoren

Kennzahlen

  • Price $535.38
  • Market cap $42.2B
  • P/E (ttm) 37.6
  • Div yield none
  • 52-wk range $518.55 – $769.98
  • Index rank #250 / #77

Wichtigste Risiken

  • Premium multiple meets slowing vet-clinic visits (Shareholders) — MED
  • Pet spending proves discretionary in a downturn (Shareholders) — MED
  • Competition from Zoetis and Mars-owned Antech (Shareholders) — LOW
  • New cancer and cardiac tests must actually sell (Shareholders) — LOW

Fazit

A wonderful business at a price that still assumes the pet boom resumes.

Interaktive Analyse öffnen →

Recherche, keine Anlageberatung.

⚠️ Independent research for a video, not financial advice. Figures from public sources/aggregators, can be stale; risk scores are editorial estimates. Verify before relying on any of it.